Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7214 p313
7 September 2002

This article
Reprint
Photocopy


News summary

Related websites
European Society of Cardiology (www.escardio.org)


Statin head-to-head

Rosuvastatin (Crestor) decreases low density lipoprotein-cholesterol in patients with hypercholesterolaemia to a greater extent than atorvastatin (Lipitor), a study funded by AstraZeneca shows.

Data were presented at the European Society of Cardiology congress in Berlin this week.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal